3D打印
透皮
生物加工
化妆品
药剂学
纳米技术
医药制造业
食品药品监督管理局
3d打印
制造工程
材料科学
计算机科学
生化工程
生物医学工程
风险分析(工程)
组织工程
医学
工程类
复合材料
病理
药理学
作者
Michael Olowe,Santosh Kumar Parupelli,Salil Desai
出处
期刊:Pharmaceutics
[MDPI AG]
日期:2022-12-01
卷期号:14 (12): 2693-2693
被引量:26
标识
DOI:10.3390/pharmaceutics14122693
摘要
Microneedles are micron-sized devices that are used for the transdermal administration of a wide range of active pharmaceutics substances with minimally invasive pain. In the past decade, various additive manufacturing technologies have been used for the fabrication of microneedles; however, they have limitations due to material compatibility and bioavailability and are time-consuming and expensive processes. Additive manufacturing (AM), which is popularly known as 3D-printing, is an innovative technology that builds three-dimensional solid objects (3D). This article provides a comprehensive review of the different 3D-printing technologies that have the potential to revolutionize the manufacturing of microneedles. The application of 3D-printed microneedles in various fields, such as drug delivery, vaccine delivery, cosmetics, therapy, tissue engineering, and diagnostics, are presented. This review also enumerates the challenges that are posed by the 3D-printing technologies, including the manufacturing cost, which limits its viability for large-scale production, the compatibility of the microneedle-based materials with human cells, and concerns around the efficient administration of large dosages of loaded microneedles. Furthermore, the optimization of microneedle design parameters and features for the best printing outcomes is of paramount interest. The Food and Drug Administration (FDA) regulatory guidelines relating to the safe use of microneedle devices are outlined. Finally, this review delineates the implementation of futuristic technologies, such as artificial intelligence algorithms, for 3D-printed microneedles and 4D-printing capabilities.
科研通智能强力驱动
Strongly Powered by AbleSci AI